EUVIMEDEUVIMED entdecken
Open Access

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC

Teijo Pellinen, Lassi Luomala, Kalle E Mattila, Annabrita Hemmes, Katja Välimäki, Mariliina Arjama, Oscar Brück, Lassi Paavolainen, Elisa Kankkunen, Harry Nisén, Petrus Järvinen, Leticia Castillon und 5 weitere

Theranostics · 2026

DOI: 10.7150/thno.118400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Teijo Pellinen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) and iCAN - Digital Precision Cancer Medicine Flagship, U…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Gelatinases, Serine Endopeptidases, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionGelatinasesSerine EndopeptidasesMembrane ProteinsCarcinoma, Renal CellKidney NeoplasmsHumansFibroblast Activation Protein AlphaEndopeptidasesTumor MicroenvironmentFemaleBiomarkers, TumorPrognosisMaleStromal Cells

Stichwörter der Autor:innen

FAPclear cell renal cell carcinomaepithelial-to-mesenchymal transitionspatial immunosuppressiontumor microenvironment

Substanzen

Fibroblast Activation Protein AlphaEndopeptidasesGelatinasesSerine EndopeptidasesMembrane ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) and iCAN - Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Department of Oncology and Radiotherapy, FICAN West Cancer Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • InFlames Research Flagship, University of Turku, Turku, Finland.
  • Hematoscope Lab, Comprehensive Cancer Center & Center of Diagnostics, Helsinki University Hospital, Helsinki, Finland & Department of Oncology, University of Helsinki, Helsinki, Finland.
  • Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Zitieren

APA

Pellinen, T., Luomala, L., Mattila, K. E., Hemmes, A., Välimäki, K., Arjama, M., Brück, O., Paavolainen, L., Kankkunen, E., Nisén, H., Järvinen, P., Castillon, L., Vanharanta, S., Vainio, P., Kallioniemi, O., Jaakkola, P. M., & Mirtti, T. (2026). Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC. Theranostics. https://doi.org/10.7150/thno.118400

Vancouver

Pellinen T, Luomala L, Mattila KE, Hemmes A, Välimäki K, Arjama M, et al. Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC. Theranostics. 2026. doi:10.7150/thno.118400

BibTeX
@article{Pellinen2026,
  author = {Pellinen, Teijo and Luomala, Lassi and Mattila, Kalle E and Hemmes, Annabrita and Välimäki, Katja and Arjama, Mariliina and Brück, Oscar and Paavolainen, Lassi and Kankkunen, Elisa and Nisén, Harry and Järvinen, Petrus and Castillon, Leticia and Vanharanta, Sakari and Vainio, Paula and Kallioniemi, Olli and Jaakkola, Panu M and Mirtti, Tuomas},
  title = {Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.118400}
}
Kostenlos starten →